HCA Healthcare, Inc. $HCA Shares Acquired by Sagespring Wealth Partners LLC

Sagespring Wealth Partners LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,140 shares of the company’s stock after purchasing an additional 769 shares during the period. Sagespring Wealth Partners LLC’s holdings in HCA Healthcare were worth $3,885,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in HCA Healthcare during the fourth quarter valued at $1,021,000. Farther Finance Advisors LLC increased its stake in HCA Healthcare by 26.9% during the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock valued at $395,000 after purchasing an additional 242 shares during the last quarter. GAMMA Investing LLC increased its stake in HCA Healthcare by 17.6% during the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock valued at $1,704,000 after purchasing an additional 737 shares during the last quarter. Stock Yards Bank & Trust Co. bought a new stake in HCA Healthcare during the first quarter valued at $394,000. Finally, Ritholtz Wealth Management increased its stake in HCA Healthcare by 19.4% during the first quarter. Ritholtz Wealth Management now owns 8,992 shares of the company’s stock valued at $3,107,000 after purchasing an additional 1,462 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of HCA opened at $410.71 on Tuesday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $439.01. The company has a 50-day moving average of $406.07 and a two-hundred day moving average of $376.56. The stock has a market cap of $96.10 billion, a price-to-earnings ratio of 17.26, a PEG ratio of 1.31 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. During the same period last year, the company posted $5.50 earnings per share. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Wolfe Research cut shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. The Goldman Sachs Group set a $470.00 price target on shares of HCA Healthcare in a research note on Tuesday. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday, July 16th. UBS Group set a $465.00 price target on shares of HCA Healthcare in a research note on Wednesday, October 8th. Finally, Royal Bank Of Canada reduced their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research note on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $425.71.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.